CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- Gross profit, 2025
- $748M
- YoY, 2025
- +12.7%
- 5-year CAGR
- +16.5%
Gross profit
Gross profit by fiscal year
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $748M | +12.7% |
| 2024 | $664M | +39.6% |
| 2023 | $476M | +20.0% |
| 2022 | $396M | +9.9% |
| 2021 | $361M | +3.6% |
| 2020 | $348M | +15.7% |
| 2019 | $301M | +22.3% |
| 2018 | $246M | +58.1% |
| 2017 | $156M | +96.4% |
| 2016 | $79M | — |